1Greenlee RT, Hi Harmon MB, Murray T, et al. Cancer Statistics. CA Cancer J Clin,2001,51:15 -36.
2Laufer M, Ranalingom S, Schoenberg MP, et al. Intravesical Gemcitabine therapy for superficial transitional cell carcinoma of the bladder phase. Ⅰ and pharmacokinetic study. J Clin Oncol, 2003,21 : 697 - 703.
3Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics. CA Cancer J Clin, 1999,49:33 -64.
4Shelley MD, Court JB, Kynaston H, Wilt TJ. Coles B. Mason M. Intravesical bacillus Calmette - Guerin versus mitomycin C for Ta and T1 bladder cancer. Cochrane Database of Systematic Reviews, 2003 (3) : CD003231.
5Jones PA, TaKai D. The role of DNA methylation in mammalian epigenetics. Science, 2001,293 (5532) : 1068 - 1070.
6Gonzalez - Gomez P, BelloM J , Lomas J , et al. Aberrant methylation of multiple genes in neuroblastic tumors : relationship w ith M YCN amp lification and allelic status atlp. European Jounal of Cancer, 2003, 39(10) : 1478-1485.
7Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a HAS association domain family protein from lung tumor suppressor locus 3p21. 3. Nat Genet, 2000, 25:315-319.
8Lee MG, Kim HY, Byun DS,et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res,2001,61 ( 18 ) : 6688 - 6692.
9Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res,2001,61 (24) :8659 -8663.
10Chan MW, Chan LW, Tang NL,et al. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Int J Cancer, 2003,104 ( 5 ) : 611 - 616.
2Salah Z, Aqeilan R, Huebner K. WWOX gene and gene product: tumor suppression through specific protein interactions[J]. Future Oncol, 2010,6 ( 2 ) : 249-259.
3Bednarek AK, Laflin K J, Daniel RL, et al. WWOX, a novel WW domain-containing protein mapping to human chro- mosome 16q23. 3 24. 1, a region frequently affected in breast Cancer[J]. Cancer Res, 2000,60(8) : 2140-2145.
4Bouteille N, Driouch K, Hage PE, et al. Inhibition of the Wnt/beta catenin pathway by the WWOX tumor suppres- sor protein[J]. Oncogene, 2009,28 ( 28 ) : 2569-2580.
5Est6cio MR, Issa JP. Dissecting DNA hypermethylation in Cancer[J]. FEBS Lett, 2011,585 ( 13 ) 2078-2086.
6Chung W;Bondaruk J,Jelinek J,et al. Detection of blad der Cancer using novel DNA methylation biomarkers in urine sediments [J]. Cancer Epidemiol Biomarkers Prey, 2011,20(7) .. 1483-1491.
7Pu RT, Laitala LE, Clark DP. Methylation profiling of urothelial carcinoma in bladder biopsy and urine]J]. Acta Cytol,2006,50(5) ..499-506.
